Drug Trial Radar · NCT04616196
Study of NKTR 255 in Combination With Cetuximab in Solid Tumors
Last checked: Nov 19, 2026Latest source record: Jun 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Oct 30, 2020
Primary completion
Mar 30, 2023
Study completion Mar 30, 2023
Sponsor
- Lead sponsor
- Nektar TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Nov 4, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1b/2, open-label multicenter study evaluating NKTR-255 as a monotherapy and together with cetuximab in patients with head and neck squamous cell carcinoma (HNSCC) and colorectal carcinoma (CRC).
Conditions
- Head and Neck Squamous Cell Carcinoma
- Colorectal Cancer
Interventions
NKTR-255Drug
NKTR-255 IV every 21 days
CetuximabDrug
Cetuximab will be given at specified doses on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-Emergent Adverse Events (TEAE) and Serious Adverse Events (SAE) of NKTR-255 in Combination With Cetuximab in R/R HNSCC or CRC for Phase 1b Dose EscalationTime frame: 60 days after the last dose of study treatment, up to an average of 6 months.
- The Maximum Tolerated Dose (MTD) and/or Recommended Phase 2 Dose (RP2D) of NKTR-255 in Combination With Cetuximab in R/R HNSCC or CRC for Phase 1b Dose EscalationTime frame: Up to 21 days
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
University of California, San Diego
San Diego, California
University of California, San Francisco
San Francisco, California
University of Minnesota
Minneapolis, Minnesota
Mary Crowley Cancer Research
Dallas, Texas
MD Anderson Cancer Center
Houston, Texas
START Center for Cancer Care
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.